Oral contraceptive use among women in the military and the general U.S. population

Journal of Women's Health

Volumn 19, Issue 5, 2010, Pages 839-845

  Enewold, Lindsey ^a   Brinton, Louise A ^b   McGlynn, Katherine A ^b   Zahm, Shelia H ^b   Potter, John F ^a,c   Zhu, Kangmin ^a,c  

^a WALTER REED ARMY MEDICAL CENTER   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

^c UNIFORMED SERVICES UNIVERSITY OF THE HEALTH SCIENCES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGE DISTRIBUTION; AIR FORCE; ARMY; ARTICLE; CONTROLLED STUDY; ETHNIC DIFFERENCE; FEMALE; HEALTH BEHAVIOR; HISPANIC; HUMAN; ORAL CONTRACEPTION; PRIORITY JOURNAL; RACE DIFFERENCE; SOLDIER; UNITED STATES; WOMEN'S HEALTH;

ADULT; AGE DISTRIBUTION; CONTRACEPTION; CONTRACEPTIVES, ORAL; FEMALE; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; MIDDLE AGED; MILITARY PERSONNEL; QUESTIONNAIRES; UNITED STATES; YOUNG ADULT;

EID: 77952369737     PISSN: 15409996     EISSN: None     Source Type: Journal    
DOI: 10.1089/jwh.2009.1706     Document Type: Article

References (43)

1. Practice Committee of the American Society for Reproductive Medicine. Hormonal contraception: Recent advances and controversies. Fertil Steril 2008;90:S103-113.
2. Kiley J, Hammond C. Combined oral contraceptive: A comprehensive review. Clin Obstet Gynecol 2007;50:868-877.
3. Rosenfield RL. What every physician should know about polycystic ovary syndrome. Dermatol Ther 2008;21:354-361.
4. Shufelt CL, Bairey Merz CN. Contraceptive hormone use and cardiovascular disease. J Am Coll Cardiol 2009;53:221-231.
5. Hannaford P, Selvaraj S, Elliott A, Angus V, Iversen L, Lee A. Cancer risk among users of oral contraceptives: Cohort data from the Royal College of General Practitioner's oral contraception study. BMJ 2007;335:651.
6. Schlesselman J. Risk of endometrial cancer in relation to use of combined oral contraceptives. A practitioner's guide to meta-analysis. Hum Reprod 1997;12:1851-1863.
7. Vessey M, Painter R. Oral contraceptive use and cancer. Findings in a large cohort study, 1968-2004. Br J Cancer 2006;95:385-389.
8. Antoniou A, Rookus M, Andrieu N, et al. Reproductive and hormonal factors, and ovarian cancer risk for BRCA1 and BRCA2 mutation carriers: Results from the International BRCA1=2 Carrier Cohort Study. Cancer Epidemiol Bio-markers Prev 2009;18:601-610.
9. Collaborative Group on Epidemiological Studies of Ovarian Cancer, Beral V, Doll R, Hermon C, Peto R, Reeves G. Ovarian cancer and oral contraceptives: Collaborative re-analysis of data from 45 epidemiological studies including 23,257 women with ovarian cancer and 87,303 controls. Lancet 2008;371:303-314.
10. Lurie G, Wilkens L, Thompson P, et al. Combined oral contraceptive use and epithelial ovarian cancer risk: Time-related effects. Epidemiology 2008;19:237-243.
11. Tworoger S, Fairfield K, Colditz G, Rosner B, Hankinson S. Association of oral contraceptive use, other contraceptive methods, and infertility with ovarian cancer risk. Am J Epidemiol 2007;166:894-901.
12. Fernandez E, La Vecchia C, Balducci A, Chatenoud L, Franceschi S, Negri E. Oral contraceptives and colorectal cancer risk: A meta-analysis. Br J Cancer 2001;84: 722-727. (Pubitemid 32239011)
13. Nichols H, Trentham-Dietz A, Hampton J, Newcomb P. Oral contraceptive use, reproductive factors, and colorectal cancer risk: Findings from Wisconsin. Cancer Epidemiol Bio-markers Prev 2005;14:1212-1218.
14. Maheshwari S, Sarraj A, Kramer J, El-Serag H. Oral contraception and the risk of hepatocellular carcinoma. J Hepatol 2007;47:506-513.
15. International Collaboration of Epidemiological Studies of Cervical Cancer. Comparison of risk factors for invasive squamous cell carcinoma and adenocarcinoma of the cervix: Collaborative reanalysis of individual data on 8,097 women with squamous cell carcinoma and 1,374 women with adenocarcinoma from 12 epidemiological studies. Int J Cancer 2006;120:885-891.
16. Moreno V, Bosch FX, Muñoz N, et al. Effect of oral contraceptives on risk of cervical cancer in women with human papillomavirus infection: The IARC multicentric case-control study. Lancet 2002;359:1085-1092.
17. Breast cancer and hormonal contraceptives: Collaborative reanalysis of individual data on 53,297 women with breast cancer and 100,239 women without breast cancer from 54 epidemiological studies. Collaborative Group on Hormonal Factors in Breast Cancer. Lancet 1996;347:1713-1727.
18. Althuis MD, Brogan DD, Coates RJ, et al. Breast cancers among very young premenopausal women (United States). Cancer Causes Control 2003;14:151-160.
19. Folger SG, Marchbanks PA, McDonald JA, et al. Risk of breast cancer associated with short-term use of oral contraceptives. Cancer Causes Control 2007;18:189-198.
20. Kahlenborn C, Modugno F, Potter DM, Severs WB. Oralcontraceptive use as a risk factor for premenopausal breast cancer: A meta-analysis. Mayo Clin Proc 2006;81: 1290-1302.
21. Marchbanks PA, McDonald JA, Wilson HG, et al. Oral contraceptives and the risk of breast cancer. N Engl J Med 2002;346:2025-2032.
22. Zhu K, Devesa SS, Wu H, et al. Cancer incidence in the U.S. military population: comparison with rates from the SEER program. Cancer Epidemiol Biomarkers 2009;18:1740-1745.
23. Committee on the Youth Population and Military Recruitment: Physical, medical, and mental health standards. Assessing fitness for military enlistment physical, medical, and mental health standards. Washington, DC: The National Academies Press, 2006.
24. Department of the Army. Medical services: Standards of medical fitness. Army Regulation 40-501, 2007.
25. Rennix CP, Quinn MM, Amoroso PJ, Eisen EA, Wegman DH. Risk of breast cancer among enlisted Army women occupationally exposed to volatile organic compounds. Am J Ind Med 2005;48:157-167.
26. Ritchie E. Issues for military women in deployment: An overview. Mil Med 2001;166:1033-1037.
27. Christopher LA, Miller L. Women in war: Operational issues of menstruation and unintended pregnancy. Mil Med 2007; 172:9-16.
28. TRICARE Management Activity. Uniform formulary medical necessity criteria for contraceptives. Available at www.tricaremil=pharmacy=Contraceptives- criteriacfm Accessed February 23, 2009.
29. Centers for Disease Control and Prevention. Continuous NHANES Web Tutorial Home.
30. Dye BA, Barker LK, Selwitz RH, et al. Overview and quality assurance for the National Health and Nutrition Examination Survey (NHANES) oral health component, 1999-2002. Community Dent Oral Epidemiol 2007;35: 140-151.
31. Powell-Dunford NC, Deuster PA, Claybaugh JR, Chapin MG. Attitudes and knowledge about continuous oral contraceptive pill use in military women. Mil Med 2003;168: 922-928.
32. Schneider MB, Fisher M, Friedman SB, Bijur PE, Toffler AP. Menstrual and premenstrual issues in female military cadets: A unique population with significant concerns. J Pediatr Adolesc Gynecol 1999;12:195-201.
33. Gehlbach D. Contraceptive needs, complications, and new directions for research. Womens Health Issues 1996;6: 355-358.
34. Operational obstetrics and gynecology, 2nd ed. Navmedpub 6300-2C. Washington, DC: Department of the Navy, 2001.
35. Nischan P, Ebeling K, Thomas DB, Hirsch U. Comparison of recalled and validated oral contraceptive histories. Am J Epidemiol 1993;138:697-703.
36. Norell SE, Boethius G, Persson I. Oral contraceptive use: Interview data versus pharmacy records. Int J Epidemiol 1998;27:1033-1037.
37. Esposito D, Schone E, Williams T, et al. Prevalence of unclaimed prescriptions at military pharmacies. J Manag Care Pharm 2008;14:541-552.
38. Althuis MD, Brogan DR, Coates RJ, et al. Hormonal content and potency of oral contraceptives and breast cancer risk among young women. Br J Cancer 2003;88:50-57.
39. Maxwell GL, Schildkraut JM, Calingaert B, et al. Progestin and estrogen potency of combination oral contraceptives and endometrial cancer risk. Gynecol Oncol 2006;103: 535-540.
40. Schrager S. Abnormal uterine bleeding associated with hormonal contraception. Am Fam Physician 2002;65:2073-2080.
41. Berenson A, Rahman M, Wilkinson G. Racial difference in the correlates of bone mineral content=density and age at peak among reproductive-aged women. Osteoporos Int 2009;20:1439-1449.
42. Heavey E, Moysich K, Hyland A, Druschel C, Sill M. Differences in contraceptive choice among female adolescents at a state-funded family planning clinic. J Midwifery Womens Health 2008;53:45-52. (Pubitemid 350286873)
43. Thurman A, Hammond N, Brown H, Roddy M. Preventing repeat teen pregnancy: Postpartum depot medroxyprogesterone acetate, oral contraceptive pills, or the patch? J Pediatr Adolesc Gynecol 2007;20:61-65.